These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25496149)

  • 21. Biobank Finances: A Socio-Economic Analysis and Review.
    Gee S; Oliver R; Corfield J; Georghiou L; Yuille M
    Biopreserv Biobank; 2015 Dec; 13(6):435-51. PubMed ID: 26697914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancing Professionalization of Biobank Business Operations: Performance and Utilization.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019 Jun; 17(3):213-218. PubMed ID: 31188630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Start-up of a clinical sample processing, storage and management platform: organisation and development of the REDinREN Biobank.
    Calleros L; Cortés MA; Luengo A; Mora I; Guijarro B; Martín P; Ortiz-Arduán A; Selgas R; Rodríguez-Puyol D; Rodríguez-Puyol M
    Nefrologia; 2012; 32(1):28-34. PubMed ID: 22294002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bridging the financial gap through providing contract services: a model for publicly funded clinical biobanks.
    Kozlakidis Z; Mant C; Cason J
    Biopreserv Biobank; 2012 Aug; 10(4):357-60. PubMed ID: 24849884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
    Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
    Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biobank and Pathology Facility: A Successful Combination.
    Alves A; Gibbon A; Carvalho S; Rodriguez-Justo M; Miranda E
    J Biomol Tech; 2022 Apr; 33(1):. PubMed ID: 35837002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Plan for Academic Biobank Solvency-Leveraging Resources and Applying Business Processes to Improve Sustainability.
    Uzarski D; Burke J; Turner B; Vroom J; Short N
    Clin Transl Sci; 2015 Oct; 8(5):553-7. PubMed ID: 25996355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advancing Professionalization of Biobank Business Operations: A Worldwide Survey.
    Henderson MK; Goldring K; Simeon-Dubach D
    Biopreserv Biobank; 2019; 17(1):71-75. PubMed ID: 30412417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The challenge of sustaining a hospital-based biobank and core molecular laboratory: the Beaumont experience.
    Wilson GD; D'Angelo K; Pruetz BL; Geddes TJ; Larson DM; Akervall J
    Biopreserv Biobank; 2014 Oct; 12(5):306-11. PubMed ID: 25314610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stakeholder analysis: a useful tool for biobank planning.
    Bjugn R; Casati B
    Biopreserv Biobank; 2012 Jun; 10(3):239-44. PubMed ID: 24835062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of a business model to assure financial sustainability of biobanks.
    Warth R; Perren A
    Biopreserv Biobank; 2014 Dec; 12(6):389-94. PubMed ID: 25496150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward a Synergistic Operating Model for Westmead Research Hub Biobanks: A Questionnaire Study.
    St George G; Wang XM; Linton J; Douglas N; Carpenter JE; Clarke CL; Heads JA
    Biopreserv Biobank; 2019 Dec; 17(6):570-576. PubMed ID: 31429584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost model for biobanks.
    Gonzalez-Sanchez MB; Lopez-Valeiras E; Morente MM; Fernández Lago O
    Biopreserv Biobank; 2013 Oct; 11(5):272-7. PubMed ID: 24835258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The case of biobank with the law: between a legal and scientific fiction.
    Sándor J; Bárd P; Tamburrini C; Tännsjö T
    J Med Ethics; 2012 Jun; 38(6):347-50. PubMed ID: 21947810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishing and sustaining a biorepository network in Israel: challenges and progress.
    Cohen Y; Almog R; Onn A; Itzhaki-Alfia A; Meir K
    Biopreserv Biobank; 2013 Dec; 11(6):331-8. PubMed ID: 24835362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'Access arrangements' for biobanks: a fine line between facilitating and hindering collaboration.
    Fortin S; Pathmasiri S; Grintuch R; Deschênes M
    Public Health Genomics; 2011; 14(2):104-14. PubMed ID: 20689244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biobankonomics: the sustainability indicators of biobanks].
    Sqalli H; El Awadi N; Rancati C
    Med Sci (Paris); 2020 Mar; 36(3):282-285. PubMed ID: 32228851
    [No Abstract]   [Full Text] [Related]  

  • 38. Addressing the Challenge of Financial Sustainability in Biobanking.
    Campos AH; Schreeder M; Parry-Jones A; Abdelhafiz AS; Larson D; Pruetz B; Geddes T; Salman A; Lazaris A
    Biopreserv Biobank; 2015 Dec; 13(6):387-95. PubMed ID: 26697907
    [No Abstract]   [Full Text] [Related]  

  • 39. Traditional and electronic informed consent for biobanking: a survey of U.S. biobanks.
    Simon CM; Klein DW; Schartz HA
    Biopreserv Biobank; 2014 Dec; 12(6):423-9. PubMed ID: 25496155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current practices for access, compensation, and prioritization in biobanks. Results from an interview study.
    Langhof H; Kahrass H; Illig T; Jahns R; Strech D
    Eur J Hum Genet; 2018 Nov; 26(11):1572-1581. PubMed ID: 30089824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.